Fresh analysis indicates that people who discontinue new weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who stop traditional lifestyle plans.
Findings released in a prominent health publication points out that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.
"Individuals buying these medications must be informed of the danger of quick rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.
This pace of regain means a reversion to original weight within about one and a half years.
Weighing Therapies
The research, which reviewed dozens of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.
Scientists point out that people who shed pounds through dieting generally experience a slower creep back—around 0.1 kg a month—post-intervention.
Understanding the Fast Regain
Experts propose the mode of action of the drugs explains the amplified rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication leads to appetite is uncontrolled, making overeating a significant risk."
An Ongoing Issue?
Health authorities advise the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of relapse, the treatment should be considered life-long.
This perspective is echoed by pharmaceutical companies, who say that the findings "underscore the long-term nature of excess weight," comparing it to managing diseases like diabetes.
Patient Accounts
Individuals who have come off the medication describe a intense resurgence of cravings.
"I experienced a trigger activating and you become extremely hungry," recalled one woman.
The struggle is compounded if users have not developed lasting dietary or behavioural modifications during therapy.
Growing Interest
Survey data suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Use is higher among women compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the drugs through private healthcare rather than public health services.
Finally, researchers emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a magic cure and maintained weight loss likely depends on integrated lifestyle management.
